Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Malignant Solid Tumors × pegfilgrastim × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Breast Neoplasms 7 Neutropenia 3 Lymphoma, Non-Hodgkin 2 Ovarian Neoplasms 1 Malignant Solid Tumors 1 Lymphoma 1 Lung Neoplasms 1 Fever 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

pegylated granulocyte colony-stimulating factor 1 pegfilgrastim 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02805166 2016-06-17

PEG-rhG-CSF in Patients With Malignant Solid Tumors Receiving Chemotherapy

CSPC Baike (Shandong) Biopharmaceutical Co., Ltd.

Phase 4 Completed

Other solid neoplasm

Malignant Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡